Status:
TERMINATED
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Stage I Adenoid Cystic Carcinoma of the Oral Cavity
Stage I Mucoepidermoid Carcinoma of the Oral Cavity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient's response ...
Detailed Description
OBJECTIVES: I. To assess the prevalence of esophageal pathology (any esophageal abnormality, specifically: esophagitis, stricture/web, infections, neoplasms) as identified by esophagoscopy in patient...
Eligibility Criteria
Inclusion
- Inclusion
- Written informed consent must be obtained from all participants prior to beginning therapy; participants should have the ability to understand and be willing to sign a written informed consent document
- Primary diagnosis of head and neck carcinoma (oral, hypopharyngeal, laryngeal)
- Stage I-IV, undergoing treatment with radiation therapy +/- chemotherapy
- Exclusion
- Medical history of esophageal dysfunction
- Pregnant women are not excluded from participation
Exclusion
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01164566
Start Date
December 1 2010
End Date
March 1 2012
Last Update
July 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157